CASP RCT Checklist PDF
CASP RCT Checklist PDF
Section A: Is the basic study design valid for a randomised controlled trial?
3. Were all participants who entered the study Yes No Can’t tell
accounted for at its conclusion? □ □ □
CONSIDER:
• Were losses to follow-up and
exclusions after randomisation
accounted for?
• Were participants analysed in the
study groups to which they were
randomised
(intention-to-treat analysis)?
• Was the study stopped early? If so,
what was the reason?
5. Were the study groups similar at the start of Yes No Can’t tell
the randomised controlled trial? □ □ □
CONSIDER:
• Were the baseline characteristics of each
study group (e.g. age, sex,
socio-economic group) clearly set out?
• Were there any differences between
the study groups that could affect the
outcome/s?
CONSIDER:
• Was there a clearly defined study
protocol?
• If any additional
interventions were given (e.g. tests or
treatments), were they similar between
the study groups?
• Were the follow-up intervals the same
for each study group?
CONSIDER:
• Were confidence intervals (CIs) reported?
CONSIDER:
• What resources are needed to introduce
this intervention taking into account
time,
finances, and skills development or
training needs?
• Are you able to disinvest resources in
one or more existing interventions in
order to
be able to re-invest in the new
intervention?
APPRAISAL SUMMARY: Record key points from your critical appraisal in this box. What is your
conclusion about the paper? Would you use it to change your practice or to recommend
changes to care/interventions used by your organisation? Could you judiciously implement this
intervention without delay?